A New Standard Is Set for Institutional Review Boards With AI Solution

Univo IRB, today’s fastest growing central IRB, and a pioneering leader in ethics review and research oversight, announced a major milestone in the evolution of institutional review board (IRB) operations with the official launch of AI workflows and continuous features available through their revolutionary IRB platform, OneVerse. The platform seamlessly integrates artificial intelligence (AI) into IRB workflows, allowing for unparalleled speed and quality of administrative tasks, which creates time and space for human oversight, interactions, and a top-rated customer experience.

Institutional review boards play a vital role in safeguarding the rights and welfare of human research participants. For decades, IRB operations relied on time-intensive processes, human-driven repetitive tasks, and fragmented outdated technology. Recognizing a critical need for modernization, Univo IRB developed OneVerse. With continuous development and user feedback from a dedicated OneVerse Innovation Council, Univo IRB has now harnessed the power of AI to introduce unparalleled speed, accuracy, and scalability directly into IRB workflows.

“With OneVerse, we are fundamentally redefining how IRBs operate,” said Julie Blasingim, Chief Executive Officer of Univo IRB. “Our platform empowers the research community with smarter, faster, and more consistent ethical review, ensuring that research remains both rigorous and responsive to the pace of scientific innovation. We are proud to see that our leadership in this area is driving continuous improvement of IRB technology across the industry.”

While some IRB companies have adopted digital tools for document management or scheduling, Univo IRB has been able to weave advanced AI algorithms into the IRB workflow. Leveraging data from thousands of reviews, Univo IRB can forecast review timelines and pinpoint bottlenecks, enabling organizations to plan and allocate resources efficiently.

By being the first to fully realize AI’s potential in the IRB context, Univo IRB is delivering a suite of efficiencies never before possible in the industry. Early adopters of Univo IRB report:

• Up to 60% reduction in average turnaround times
• Significant decreases in administrative overhead
• Faster and higher accuracy of reviewed materials
• More consistency in IRB determinations
• Greater customer satisfaction and human support among site research teams, IRB members, and sponsor/CRO teams

OneVerse is designed to enhance, not replace, the judgment and expertise of IRB professionals. The platform’s AI acts as an intelligent assistant, flagging complex or ambiguous issues for human deliberation and supporting board members in their ethical decision-making.

“AI can process vast quantities of information and recognize patterns at a scale that is simply not feasible for humans alone,” explained Heather Fitzgerald, Vice President of Operations of Univo IRB. “Ethical review is a fundamentally human endeavor. OneVerse is built to support IRB professionals, freeing them from repetitive work so they can focus on nuanced and mission-critical discussions and the voice of patients.”

With OneVerse, Univo IRB is laying the foundation for a next-generation research ecosystem where ethical oversight is both rigorous and agile. As scientific research accelerates and expands into new domains, from AI-driven medicine to global health studies, IRBs must evolve to keep pace with emerging challenges and Univo IRB is at the forefront.

About Univo IRB

Univo IRB is a next generation institutional review board (IRB) specializing in the ethical review of Phase I-IV pharmaceutical, device, biologic, behavioral, and psycho-social research. We offer agile study approaches, expert solutions powered by industry-leading study technology, and a service-first approach. Univo IRB holds accreditation through the Association for the Accreditation of Human Research Protection Programs (AAHRPP). With support from senior advisors and combined 100+ years of industry experience, Univo IRB guides your study to approval while respecting the rights and welfare of patients every step of the way.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250908838683/en/

UnivoIRB enhances the industry’s IRB experience and IRB technology with the continued advancements of OneVerse® and AI-powered workflows to accelerate the IRB process.